OptumRx and OptumInsight May Witness Robust Growth Trends in 2017
In 1Q17, UnitedHealth Group’s (UNH) Optum business reported $21.2 billion in revenues, which represents year-over-year growth of around 7.9%.
In 1Q17, UnitedHealth Group’s (UNH) UnitedHealthcare business witnessed a 2.5 million year-over-year increase in customers.
In 1Q17, UnitedHealth Group (UNH) witnessed a year-over-year increase of 70 basis points in its medical care ratio.
In 1Q17, UnitedHealth Group’s (UNH) OptumHealth segment served 6 million more people on a year-over-year basis.
UnitedHealth Group (UNH) posted its 1Q17 earnings on April 18, 2017. During the quarter, UNH reported revenues of ~$48.5 billion, which represents year-over-year growth of ~9.4%.
Analysts expect Alcon’s 1Q17 revenues to fall due to lower equipment sales in the surgical franchise and lower sales in contact lens products.
As OptumCare continues to branch out across multiple markets, it may have a favorable impact on reducing UnitedHealth Group’s medical care ratio.
In its bid to control healthcare costs, UnitedHealth Group’s (UNH) OptumRx segment has been actively deploying data analytics across its Optum platform.
UnitedHealth Group’s (UNH) Optum One is being used by about 700 hospitals and 7,000 medical clinics, which together cover about 140,000 healthcare providers.
UnitedHealth Group (UNH) has projected that in 2016, revenues for its OptumHealth segment will grow 14.0%–17.0% YoY.
Optum360, UnitedHealth Group’s (UNH) hospital revenue cycle management solution, is expected to reach $60.0 billion in billings for clients and partner organizations.
Wall Street analysts have projected UnitedHealth Group’s 2016 revenues to be about $183.9 billion, which is a YoY growth of 17.1%.
The consensus 12-month target price for UnitedHealth Group’s stock is ~$152.60, which represents a rise of 8.8% from the stock’s closing price of $140.30 on July 11, 2016.
In 2Q16, Wall Street analysts expect UnitedHealth Group to report adjusted EPS (earnings per share) of approximately $1.90.
UnitedHealth Group will release its 2Q16 earnings on July 19, 2016. Wall Street analysts estimate that UnitedHealth Group’s (UNH) revenues will reach approximately $45.0 billion in 2Q16.
In a Bloomberg survey of 23 brokerage firms reported on April 28, 2016, ~61.9% of the analysts rated Anthem as a “buy,” while 38.1% rated it as a “hold.”
In its 1Q16 conference call, Anthem updated its 2016 revenue guidance to $81 billion–$82 billion—higher than the previous projection by about $1 billion.
In 1Q16, Anthem’s (ANTM) medical care ratio, which measures medical costs against premium revenues, rose by 1.6% on a YoY (year-over-year) basis.
In 1Q16, Anthem’s (ANTM) public exchange enrollment witnessed a sequential increase of about 184,000 members and reached 975,000 lives.
Anthem’s government-sponsored business, including Medicare, Medicaid, and Federal Employee Program enrollments, earned revenues of $10.8 billion in 1Q16.